 | • レポートコード：D0804-10378 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ポラクタントアルファの世界市場を広く調査・分析し、今後の市場展望をまとめております。ポラクタントアルファの種類別市場規模（迅速投与、微量投与）、用途別市場規模（サルベージ治療、呼吸窮迫症候群（RDS）予防）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Chiesi、Mylan、Douglas Pharma、Takeda、Piramal ・地域別グローバル市場分析 2015年-2020年 ・ポラクタントアルファの北米市場（アメリカ、カナダ、メキシコ） ・ポラクタントアルファのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ポラクタントアルファのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ポラクタントアルファの南米市場（ブラジル、アルゼンチン） ・ポラクタントアルファの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：迅速投与、微量投与 ・用途別分析：サルベージ治療、呼吸窮迫症候群（RDS）予防 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Poractant Alfa market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Poractant Alfa market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Poractant Alfa market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Poractant Alfa market has been segmented into
Rapid Dosing
Microdosing
By Application, Poractant Alfa has been segmented into:
Salvage Treatment
Prevention of Respiratory Distress Syndrome (RDS)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Poractant Alfa market presented in the report. This section sheds light on the sales growth of different regional and country-level Poractant Alfa markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Poractant Alfa market.
The report offers in-depth assessment of the growth and other aspects of the Poractant Alfa market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Poractant Alfa Market Share Analysis
Poractant Alfa competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Poractant Alfa sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Poractant Alfa sales, revenue and market share for each player covered in this report.
The major players covered in Poractant Alfa are:
Chiesi
Mylan
Douglas Pharma
Takeda
Piramal
Among other players domestic and global, Poractant Alfa market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Poractant Alfa product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Poractant Alfa, with price, sales, revenue and global market share of Poractant Alfa in 2018 and 2019.
Chapter 3, the Poractant Alfa competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poractant Alfa breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Poractant Alfa market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Poractant Alfa sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Poractant Alfa Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Poractant Alfa Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Rapid Dosing
1.2.3 Microdosing
1.3 Market Analysis by Application
1.3.1 Overview: Global Poractant Alfa Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Salvage Treatment
1.3.3 Prevention of Respiratory Distress Syndrome (RDS)
1.4 Overview of Global Poractant Alfa Market
1.4.1 Global Poractant Alfa Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Chiesi
2.1.1 Chiesi Details
2.1.2 Chiesi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Chiesi SWOT Analysis
2.1.4 Chiesi Product and Services
2.1.5 Chiesi Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Douglas Pharma
2.3.1 Douglas Pharma Details
2.3.2 Douglas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Douglas Pharma SWOT Analysis
2.3.4 Douglas Pharma Product and Services
2.3.5 Douglas Pharma Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Piramal
2.5.1 Piramal Details
2.5.2 Piramal Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Piramal SWOT Analysis
2.5.4 Piramal Product and Services
2.5.5 Piramal Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Poractant Alfa Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Poractant Alfa Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Poractant Alfa Manufacturer Market Share in 2019
3.3.2 Top 6 Poractant Alfa Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Poractant Alfa Sales, Revenue and Market Share by Regions
4.1.1 Global Poractant Alfa Sales and Market Share by Regions (2015-2020)
4.1.2 Global Poractant Alfa Revenue and Market Share by Regions (2015-2020)
4.2 North America Poractant Alfa Sales and Growth Rate (2015-2020)
4.3 Europe Poractant Alfa Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Poractant Alfa Sales and Growth Rate (2015-2020)
4.5 South America Poractant Alfa Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Poractant Alfa Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Poractant Alfa Sales, Revenue and Market Share by Country
5.1.1 North America Poractant Alfa Sales and Market Share by Country (2015-2020)
5.1.2 North America Poractant Alfa Revenue and Market Share by Country (2015-2020)
5.2 United States Poractant Alfa Sales and Growth Rate (2015-2020)
5.3 Canada Poractant Alfa Sales and Growth Rate (2015-2020)
5.4 Mexico Poractant Alfa Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Poractant Alfa Sales, Revenue and Market Share by Country
6.1.1 Europe Poractant Alfa Sales and Market Share by Country (2015-2020)
6.1.2 Europe Poractant Alfa Revenue and Market Share by Country (2015-2020)
6.2 Germany Poractant Alfa Sales and Growth Rate (2015-2020)
6.3 UK Poractant Alfa Sales and Growth Rate (2015-2020)
6.4 France Poractant Alfa Sales and Growth Rate (2015-2020)
6.5 Russia Poractant Alfa Sales and Growth Rate (2015-2020)
6.6 Italy Poractant Alfa Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Poractant Alfa Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Poractant Alfa Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Poractant Alfa Revenue and Market Share by Regions (2015-2020)
7.2 China Poractant Alfa Sales and Growth Rate (2015-2020)
7.3 Japan Poractant Alfa Sales and Growth Rate (2015-2020)
7.4 Korea Poractant Alfa Sales and Growth Rate (2015-2020)
7.5 India Poractant Alfa Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Poractant Alfa Sales and Growth Rate (2015-2020)
7.7 Australia Poractant Alfa Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Poractant Alfa Sales, Revenue and Market Share by Country
8.1.1 South America Poractant Alfa Sales and Market Share by Country (2015-2020)
8.1.2 South America Poractant Alfa Revenue and Market Share by Country (2015-2020)
8.2 Brazil Poractant Alfa Sales and Growth Rate (2015-2020)
8.3 Argentina Poractant Alfa Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Poractant Alfa Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Poractant Alfa Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Poractant Alfa Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Poractant Alfa Sales and Growth Rate (2015-2020)
9.3 Turkey Poractant Alfa Sales and Growth Rate (2015-2020)
9.4 Egypt Poractant Alfa Sales and Growth Rate (2015-2020)
9.5 South Africa Poractant Alfa Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Poractant Alfa Sales and Market Share by Type (2015-2020)
10.2 Global Poractant Alfa Revenue and Market Share by Type (2015-2020)
10.3 Global Poractant Alfa Price by Type (2015-2020)
11 Global Poractant Alfa Market Segment by Application
11.1 Global Poractant Alfa Sales Market Share by Application (2015-2020)
11.2 Global Poractant Alfa Revenue Market Share by Application (2015-2020)
11.3 Global Poractant Alfa Price by Application (2015-2020)
12 Market Forecast
12.1 Global Poractant Alfa Sales, Revenue and Growth Rate (2021-2025)
12.2 Poractant Alfa Market Forecast by Regions (2021-2025)
12.2.1 North America Poractant Alfa Market Forecast (2021-2025)
12.2.2 Europe Poractant Alfa Market Forecast (2021-2025)
12.2.3 Asia-Pacific Poractant Alfa Market Forecast (2021-2025)
12.2.4 South America Poractant Alfa Market Forecast (2021-2025)
12.2.5 Middle East & Africa Poractant Alfa Market Forecast (2021-2025)
12.3 Poractant Alfa Market Forecast by Type (2021-2025)
12.3.1 Global Poractant Alfa Sales Forecast by Type (2021-2025)
12.3.2 Global Poractant Alfa Market Share Forecast by Type (2021-2025)
12.4 Poractant Alfa Market Forecast by Application (2021-2025)
12.4.1 Global Poractant Alfa Sales Forecast by Application (2021-2025)
12.4.2 Global Poractant Alfa Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Poractant Alfa Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Poractant Alfa by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Poractant Alfa Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Chiesi Basic Information, Manufacturing Base and Competitors
Table 8. Chiesi Poractant Alfa Major Business
Table 9. Chiesi Poractant Alfa Total Revenue (USD Million) (2018-2019)
Table 10. Chiesi SWOT Analysis
Table 11. Chiesi Poractant Alfa Product and Services
Table 12. Chiesi Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Poractant Alfa Major Business
Table 15. Mylan Poractant Alfa Total Revenue (USD Million) (2018-2019)
Table 16. Mylan SWOT Analysis
Table 17. Mylan Poractant Alfa Product and Services
Table 18. Mylan Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Douglas Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Douglas Pharma Poractant Alfa Major Business
Table 21. Douglas Pharma Poractant Alfa Total Revenue (USD Million) (2018-2019)
Table 22. Douglas Pharma SWOT Analysis
Table 23. Douglas Pharma Poractant Alfa Product and Services
Table 24. Douglas Pharma Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Takeda Basic Information, Manufacturing Base and Competitors
Table 26. Takeda Poractant Alfa Major Business
Table 27. Takeda Poractant Alfa Total Revenue (USD Million) (2018-2019)
Table 28. Takeda SWOT Analysis
Table 29. Takeda Poractant Alfa Product and Services
Table 30. Takeda Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Piramal Basic Information, Manufacturing Base and Competitors
Table 32. Piramal Poractant Alfa Major Business
Table 33. Piramal Poractant Alfa Total Revenue (USD Million) (2018-2019)
Table 34. Piramal SWOT Analysis
Table 35. Piramal Poractant Alfa Product and Services
Table 36. Piramal Poractant Alfa Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Poractant Alfa Sales by Manufacturer (2018-2019) (K Doses)
Table 38. Global Poractant Alfa Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Poractant Alfa Sales by Regions (2015-2020) (K Doses)
Table 40. Global Poractant Alfa Sales Market Share by Regions (2015-2020)
Table 41. Global Poractant Alfa Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Poractant Alfa Sales by Countries (2015-2020) (K Doses)
Table 43. North America Poractant Alfa Sales Market Share by Countries (2015-2020)
Table 44. North America Poractant Alfa Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Poractant Alfa Revenue Market Share by Countries (2015-2020)
Table 46. Europe Poractant Alfa Sales by Countries (2015-2020) (K Doses)
Table 47. Europe Poractant Alfa Sales Market Share by Countries (2015-2020)
Table 48. Europe Poractant Alfa Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Poractant Alfa Sales by Regions (2015-2020) (K Doses)
Table 50. Asia-Pacific Poractant Alfa Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Poractant Alfa Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Poractant Alfa Sales by Countries (2015-2020) (K Doses)
Table 53. South America Poractant Alfa Sales Market Share by Countries (2015-2020)
Table 54. South America Poractant Alfa Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Poractant Alfa Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Poractant Alfa Sales by Countries (2015-2020) (K Doses)
Table 57. Middle East & Africa Poractant Alfa Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Poractant Alfa Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Poractant Alfa Revenue Market Share by Countries (2015-2020)
Table 60. Global Poractant Alfa Sales by Type (2015-2020) (K Doses)
Table 61. Global Poractant Alfa Sales Share by Type (2015-2020)
Table 62. Global Poractant Alfa Revenue by Type (2015-2020) (USD Million)
Table 63. Global Poractant Alfa Revenue Share by Type (2015-2020)
Table 64. Global Poractant Alfa Sales by Application (2015-2020) (K Doses)
Table 65. Global Poractant Alfa Sales Share by Application (2015-2020)
Table 66. Global Poractant Alfa Sales Forecast by Regions (2021-2025) (K Doses)
Table 67. Global Poractant Alfa Market Share Forecast by Regions (2021-2025)
Table 68. Global Poractant Alfa Sales Forecast by Type (2021-2025) (K Doses)
Table 69. Global Poractant Alfa Market Share Forecast by Type (2021-2025)
Table 70. Global Poractant Alfa Sales Forecast by Application (2021-2025)
Table 71. Global Poractant Alfa Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Poractant Alfa Picture
Figure 2. Global Sales Market Share of Poractant Alfa by Type in 2019
Figure 3. Rapid Dosing Picture
Figure 4. Microdosing Picture
Figure 5. Poractant Alfa Sales Market Share by Application in 2018
Figure 6. Salvage Treatment Picture
Figure 7. Prevention of Respiratory Distress Syndrome (RDS) Picture
Figure 8. Global Poractant Alfa Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Poractant Alfa Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Poractant Alfa Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Poractant Alfa Sales Market Share by Manufacturer in 2019
Figure 29. Global Poractant Alfa Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Poractant Alfa Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Poractant Alfa Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 34. Global Poractant Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Poractant Alfa Revenue Market Share by Regions (2015-2020)
Figure 36. Global Poractant Alfa Revenue Market Share by Regions in 2018
Figure 37. North America Poractant Alfa Sales and Growth Rate (2015-2020)
Figure 38. Europe Poractant Alfa Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Poractant Alfa Sales and Growth Rate (2015-2020)
Figure 40. South America Poractant Alfa Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Poractant Alfa Sales and Growth Rate (2015-2020)
Figure 42. North America Poractant Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Poractant Alfa Sales Market Share by Countries (2015-2020)
Figure 44. North America Poractant Alfa Sales Market Share by Countries in 2018
Figure 45. North America Poractant Alfa Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Poractant Alfa Revenue Market Share by Countries in 2018
Figure 47. United States Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 48. Canada Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Mexico Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Europe Poractant Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Poractant Alfa Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Poractant Alfa Revenue Market Share by Countries in 2019
Figure 53. Germany Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. UK Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. France Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Russia Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Asia-Pacific Poractant Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Poractant Alfa Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Poractant Alfa Revenue Market Share by Regions 2019
Figure 61. China Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Korea Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. India Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Southeast Asia Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. South America Poractant Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Poractant Alfa Sales Market Share by Countries in 2019
Figure 68. South America Poractant Alfa Revenue Market Share by Countries in 2019
Figure 69. Brazil Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Middle East and Africa Poractant Alfa Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Poractant Alfa Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Poractant Alfa Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Poractant Alfa Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Egypt Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Turkey Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. South Africa Poractant Alfa Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Global Poractant Alfa Sales and Growth Rate (2021-2025) (K Doses)
Figure 80. Global Poractant Alfa Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Poractant Alfa Market Forecast (2021-2025) (K Doses)
Figure 82. Europe Sales Poractant Alfa Market Forecast (2021-2025) (K Doses)
Figure 83. Asia-Pacific Sales Poractant Alfa Market Forecast (2021-2025) (K Doses)
Figure 84. South America Sales Poractant Alfa Market Forecast (2021-2025) (K Doses)
Figure 85. Middle East & Africa Sales Poractant Alfa Market Forecast (2021-2025) (K Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Eptacog Alfa（組換えヒト凝固因子VIIa）の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Eptacog Alfa (Recombinant Human Coagulation Factor VIIa) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million i…- 汚泥処理・処理装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sludge Treatment and Disposal Equipment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sludg…
- ジメチルグリオキシムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dimethylglyoxime market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dimethylglyoxime market repo…
- 4-メルカプトフェニル酢酸の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global 4-Mercaptophenylacetic Acid market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The 4-Mercaptophenyla…
- MVR真空蒸発器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global MVR Vacuum Evaporator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The MVR Vacuum Evaporator m…